OTTMUSG00000010332 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of the protein encoded by the gene OTTMUSG00000010332, as referenced in mouse genomic data. While the exact biological function of this gene may not yet be fully understood, genes in similar categories often participate in crucial cellular processes such as intracellular signaling, gene regulation, or protein synthesis. The inhibition of OTTMUSG00000010332 prevents the protein from executing its normal role, whether that involves interacting with other proteins, catalyzing key reactions, or influencing regulatory pathways. By blocking these interactions, researchers can study the downstream effects of this disruption, offering insights into the broader biological networks in which this protein is involved.
Research into OTTMUSG00000010332 inhibitors allows scientists to dissect the role of this gene in cellular function. When the activity of OTTMUSG00000010332 is inhibited, it is possible to observe changes in cellular processes such as transcription, signal transduction, and metabolic regulation, thereby revealing the protein's specific role within these systems. Additionally, the inhibitors help uncover the interactions between OTTMUSG00000010332 and other cellular components, providing a clearer picture of how this protein integrates into complex molecular networks. The study of such inhibitors sheds light on how the regulation of this particular gene contributes to overall cellular stability, organization, and adaptability in response to environmental or internal signals. Through this approach, researchers gain valuable insights into the molecular mechanisms underlying cellular processes and the importance of gene-specific regulation in maintaining cellular homeostasis.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibitor of mTOR, Rapamycin may influence pathways associated with protein synthesis and autophagy, potentially affecting the function of PRAME like 22 isoform X1. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
A tyrosine kinase inhibitor, Dasatinib could modulate signaling pathways related to cell growth and differentiation, indirectly influencing PRAME like 22 isoform X1. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
As an inhibitor of MEK1/2, U0126 might affect the MAPK/ERK pathway, potentially impacting the signaling processes involving PRAME like 22 isoform X1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAP kinase inhibitor, SB203580 could influence inflammatory and stress response pathways potentially associated with PRAME like 22 isoform X1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibitor of PI3K, LY294002 might alter key signaling pathways related to cell survival and growth, indirectly affecting PRAME like 22 isoform X1. | ||||||
WZ 4002 | 1213269-23-8 | sc-364655 sc-364655A | 10 mg 50 mg | $180.00 $744.00 | 1 | |
A selective EGFR inhibitor, WZ4002 could modulate EGFR signaling pathways, potentially influencing PRAME like 22 isoform X1's function. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
A multikinase inhibitor, Sorafenib might impact various signaling pathways, including VEGFR and PDGFR, potentially influencing PRAME like 22 isoform X1. | ||||||
Nilotinib | 641571-10-0 | sc-202245 sc-202245A | 10 mg 25 mg | $205.00 $405.00 | 9 | |
A selective BCR-ABL inhibitor, Nilotinib could modulate oncogenic signaling pathways, potentially affecting PRAME like 22 isoform X1's activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
An MEK inhibitor, PD98059 could impact the MAPK pathway, potentially influencing cellular processes involving PRAME like 22 isoform X1. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $150.00 $920.00 | 5 | |
A receptor tyrosine kinase inhibitor, Sunitinib might influence angiogenesis and cell proliferation pathways, potentially affecting PRAME like 22 isoform X1. | ||||||